Back to search
Anticoagulant-induced Bleeding
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anticoagulant-induced Bleeding trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Anticoagulant-induced Bleeding trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The clinical significance of pulmonary embolism (PE) limited to the subsegmental pulmonary arteries, so called isolated subsegmental pulmonary embolism (SSPE),…
PANTHER-GI Pilot Study will assess the feasibility of a full-scale multicentre cohort management study evaluating the safety of a standardized strategy for resu…
There's no unified recommendation in clinical practice regarding adjusting dosages for different patient types, especially when adverse events occur. While riva…
The goal of the study is to evaluate the frequency of cardiovascular and thromboembolic complications in patients with cardiovascular disease after lower limb j…
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are recommended for stroke prevention in non-valvular atrial fibrillation (AF). Although NOACs s…